Prepared by

A recent report and press release issued by the Food and Drug Administration (FDA) assert that NJOY e-cigarette cartridges contain harmful levels of carcinogens and toxic chemicals. It was further implied that these chemicals are not found in other FDA-approved nicotine-containing products. Subsequently, a technical review and scientific analysis of the FDA’s report was performed by scientists at Exponent. Results of the review identified the following limitations: In summary, the report “Evaluation of e-cigarettes ” suffers from several limitations, that taken together result in it failing to adequately support the FDA claims of potential adverse health consequences from the use of NJOY e-cigarette products tested as compared to other FDA-approved nicotine containing products. The report failed to present standard protocols for proper study design with regards to the testing of the referenced control device, documenting the number of samples tested either within or across tests, or presenting statistical analyses when quantifiable results were obtained. The chemical content of similar nicotine-containing FDA-approved products was not completely described with respect to the presence of tobacco-specific nitrosamine